ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2827

Analysis of HLA-B27 Transgenic Rats Reveals Specific Gut Transcriptome and Microbiome Signatures Associated with Inflammation

Tejpal Gill1, Mark Asquith2, Stephen Brooks1, James T. Rosenbaum3 and Robert A. Colbert4, 1NIAMS/NIH, Bethesda, MD, 2OHSU, Portland, OR, 3Devers Eye Institute, Legacy Hospital system, Portland, OR, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Gene Expression, inflammatory bowel disease (IBD), microbiome and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: HLA-B27 and human beta 2-microglobulin expression in rats (transgenic; TG) induces a spontaneous inflammatory disease resembling human spondyloarthritis (SpA) with associated gastrointestinal inflammation. While aspects of rat SpA have been studied in detail, our understanding of gut inflammation remains limited. We recently showed that HLA-B27 affects the gut microbiota in TG rats. Therefore, the aim for our current project was to determine the association between intestinal microbiota and host gut transcriptome among TG rats developing SpA-like disease. Lewis (LEW), Fischer (F344), and Dark Agouti (DA) rats with same transgene locus (33-3) at 2, 3 and 6 months of age along with strain-specific controls were studied. TG LEW and F344 rats develop SpA beginning with colitis at about 8 weeks of age, while TG DA rats are disease resistant. Arthritis develops later in LEW and F344 TG animals, and is more variable.

Methods: To determine gut inflammation, tissue samples from cecum and colon were stained with H&E and scored for histology. Gut transcriptome differences were analyzed using Illumina HiSeq 2000 and differential gene expression was assessed. To characterize microbial profiles, 16SrRNA gene from gut microbiota was amplified and sequenced using Illumina MiSeq. Data were quality-filtered using Quantitative Insights Into Microbial Ecology (QIIME) and relative frequency was calculated.

Results: Inflammation in the cecum and colon occurred earlier and was more severe in F344 TG rats compared to LEW based on histology scores. Differential gene expression in LEW and F344 TG animals revealed marked up-regulation of IL-17 (A, F) as well as upregulation of Il23a. Interferon (IFNg) and IFN response genes were upregulated in TG rats, as were apoptotic signaling and oxidative stress pathways (upregulation of Gpx2, Nox1, Duox2 and downregulation of Apoa1). Although there was no significant gut inflammation in DA TG rats, we observed upregulation of many of these genes at 2-3 months, followed by return to normal at 6 months of age. Microbial profiling revealed increased relative frequency of Akkermansia in F344 TG and LEW TG rats. Increased abundance of Candidatus Arthromitus, a segmented filamentous bacteria (SFB) implicated in inducing Th17 responses, was detected in the F344 and LEW animals. Interestingly we were unable to detect SFB in DA, which could account for the lack of Th17 cytokines and absence of SpA including gut inflammation.

Conclusion: Transcriptome analysis of the HLA-B27 TG reveals upregulation of interferon and Il23/Il17 mediated pathways suggesting a proinflammatory shift in the immune microenvironment of the gut. In TG rats, microbial dysbiosis is associated with a decrease in Firmicutes, and an expansion of Proteobacteria, Prevotella spp. and Akkermansia muciniphila. Protective effects of DA background may be linked to the absence of SFB in the gut. Ongoing analyses underway correlating microbial communities with activation of the IL-23/IL-17 axis, IFN signaling, and oxidative stress pathways will establish links with disease severity. This should increase our understanding of SpA associated IBD and generate mechanistic hypotheses as well as potential biomarkers for diagnosis and treatment.


Disclosure: T. Gill, None; M. Asquith, None; S. Brooks, None; J. T. Rosenbaum, None; R. A. Colbert, None.

To cite this abstract in AMA style:

Gill T, Asquith M, Brooks S, Rosenbaum JT, Colbert RA. Analysis of HLA-B27 Transgenic Rats Reveals Specific Gut Transcriptome and Microbiome Signatures Associated with Inflammation [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/analysis-of-hla-b27-transgenic-rats-reveals-specific-gut-transcriptome-and-microbiome-signatures-associated-with-inflammation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-hla-b27-transgenic-rats-reveals-specific-gut-transcriptome-and-microbiome-signatures-associated-with-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology